Anika Therapeutics, Inc. (ANIK) stock
ANIKNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$12.92−0.48 (-3.58%)
Close on Nov 16, 2026Market cap $172.91MP/E –Yield –
Anika Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
Anika Therapeutics's operating margin for the twelve months ending Jun 30, 2026 was -4.2%. For fiscal 2025 it was -9.8%, against -4.3% the year before. The highest annual figure on record is 58.2% in fiscal 2014.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -9.8% | −5.5 |
| FY2024 | Dec 31, 2024 | -4.3% | −5.0 |
| FY2023 | Dec 31, 2023 | 0.7% | −2.5 |
| FY2022 | Dec 31, 2022 | 3.2% | +1.5 |
| FY2021 | Dec 31, 2021 | 1.8% | +23.5 |
| FY2020 | Dec 31, 2020 | -21.7% | −51.6 |
| FY2019 | Dec 31, 2019 | 29.9% | +9.3 |
| FY2018 | Dec 31, 2018 | 20.6% | −19.7 |
| FY2017 | Dec 31, 2017 | 40.3% | −8.6 |
| FY2016 | Dec 31, 2016 | 49.0% | −2.8 |
| FY2015 | Dec 31, 2015 | 51.8% | −6.4 |
| FY2014 | Dec 31, 2014 | 58.2% | +14.8 |
| FY2013 | Dec 31, 2013 | 43.4% | +15.8 |
| FY2012 | Dec 31, 2012 | 27.6% | +6.1 |
| FY2011 | Dec 31, 2011 | 21.6% | +8.0 |
| FY2010 | Dec 31, 2010 | 13.6% | −0.4 |
| FY2009 | Dec 31, 2009 | 13.9% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 9.1% | +23.9 |
| Q1 FY2026 | Mar 31, 2026 | -18.5% | −2.2 |
| Q4 FY2025 | Dec 31, 2025 | 2.1% | +4.4 |
| Q3 FY2025 | Sep 30, 2025 | -11.6% | −11.3 |
| Q2 FY2025 | Jun 30, 2025 | -14.8% | −8.9 |
| Q1 FY2025 | Mar 31, 2025 | -16.4% | −7.7 |
| Q4 FY2024 | Dec 31, 2024 | -2.3% | −59.8 |
| Q3 FY2024 | Sep 30, 2024 | -0.3% | +18.2 |
| Q2 FY2024 | Jun 30, 2024 | -5.9% | +2.3 |
| Q1 FY2024 | Mar 31, 2024 | -8.6% | +24.5 |
| Q4 FY2023 | Dec 31, 2023 | 57.5% | +16.1 |
| Q3 FY2023 | Sep 30, 2023 | -18.5% | −4.1 |
| Q2 FY2023 | Jun 30, 2023 | -8.2% | +0.3 |
| Q1 FY2023 | Mar 31, 2023 | -33.1% | −23.4 |
| Q4 FY2022 | Dec 31, 2022 | 41.4% | +66.9 |
| Q3 FY2022 | Sep 30, 2022 | -14.4% | −17.7 |
| Q2 FY2022 | Jun 30, 2022 | -8.5% | −32.6 |
| Q1 FY2022 | Mar 31, 2022 | -9.7% | −13.4 |
| Q4 FY2021 | Dec 31, 2021 | -25.5% | +29.5 |
| Q3 FY2021 | Sep 30, 2021 | 3.3% | +28.3 |
| Q2 FY2021 | Jun 30, 2021 | 24.1% | +55.2 |
| Q1 FY2021 | Mar 31, 2021 | 3.7% | −16.4 |
| Q4 FY2020 | Dec 31, 2020 | -54.9% | −71.1 |
| Q3 FY2020 | Sep 30, 2020 | -25.0% | −65.6 |
| Q2 FY2020 | Jun 30, 2020 | -31.1% | −70.3 |
| Q1 FY2020 | Mar 31, 2020 | 20.0% | −2.1 |
| Q4 FY2019 | Dec 31, 2019 | 16.1% | −20.1 |
| Q3 FY2019 | Sep 30, 2019 | 40.6% | +8.6 |
| Q2 FY2019 | Jun 30, 2019 | 39.2% | +2.4 |
| Q1 FY2019 | Mar 31, 2019 | 22.2% | +59.0 |
| Q4 FY2018 | Dec 31, 2018 | 36.2% | +3.1 |
| Q3 FY2018 | Sep 30, 2018 | 32.0% | −5.8 |
| Q2 FY2018 | Jun 30, 2018 | 36.8% | −16.2 |
| Q1 FY2018 | Mar 31, 2018 | -36.8% | −71.1 |
| Q4 FY2017 | Dec 31, 2017 | 33.1% | −11.2 |
| Q3 FY2017 | Sep 30, 2017 | 37.8% | −15.3 |
| Q2 FY2017 | Jun 30, 2017 | 53.0% | – |
| Q1 FY2017 | Mar 31, 2017 | 34.2% | – |
| Q4 FY2016 | Dec 31, 2016 | 44.4% | – |
| Q3 FY2016 | Sep 30, 2016 | 53.1% | – |
See a number that looks wrong?